4 Reasons Why DexCom Could Be A Good Buy For 2026
Source: SeekingAlpha
2025-12-16 07:37:14 ET
2025 Proves To Be A Damp Squib
DexCom, Inc. ( DXCM ), a large-cap proxy on the medical equipment market, hasn’t quite managed to deliver the goods for its shareholder base in 2025 so far. Admittedly, the broad medical equipment industry has hardly dazzled this year, generating returns of less than 7% (on average), which is a little more than one-third the returns of the prime equity bellwether (which DXCM is also a part of). However, our stock in focus has not even managed to stay flat but has instead lost ground by a not-insignificant threshold of -14%....
Read the full article on Seeking Alpha
For further details see:
4 Reasons Why DexCom Could Be A Good Buy For 2026
Invesco S&P 500 Equal Weight Health Care ETF
NASDAQ: RSPH
RSPH Trading
-0.67% G/L:
$30.6131 Last:
43,102 Volume:
$30.87 Open:
